Review



dht igf1  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress dht igf1
    Dht Igf1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dht+igf1/IGF-I%2FIGF-1%2C+Human/pm41816941-197-28-34
    Average 95 stars, based on 10 article reviews
    dht igf1 - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Derivative Assay:

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome.
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co-cultured with JAr spheroids, Ishikawa cells were primed under serum-free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY-P72378, Med Chem Express), DHT + IGF1 (50 ng/mL, HY-P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP-AEW541 (10 μM, HY-50866, Med Chem Express) to eliminate interference from serum-derived factors.

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co‐cultured with JAr spheroids, Ishikawa cells were primed under serum‐free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY‐ P72378 , Med Chem Express), DHT + IGF1 (50 ng/mL, HY‐P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP‐AEW541 (10 μM, HY‐50866, Med Chem Express) to eliminate interference from serum‐derived factors.

    Expressing:

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome.
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co-cultured with JAr spheroids, Ishikawa cells were primed under serum-free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY-P72378, Med Chem Express), DHT + IGF1 (50 ng/mL, HY-P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP-AEW541 (10 μM, HY-50866, Med Chem Express) to eliminate interference from serum-derived factors.

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co‐cultured with JAr spheroids, Ishikawa cells were primed under serum‐free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY‐ P72378 , Med Chem Express), DHT + IGF1 (50 ng/mL, HY‐P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP‐AEW541 (10 μM, HY‐50866, Med Chem Express) to eliminate interference from serum‐derived factors.

    Control:

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome.
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co-cultured with JAr spheroids, Ishikawa cells were primed under serum-free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY-P72378, Med Chem Express), DHT + IGF1 (50 ng/mL, HY-P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP-AEW541 (10 μM, HY-50866, Med Chem Express) to eliminate interference from serum-derived factors.

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co‐cultured with JAr spheroids, Ishikawa cells were primed under serum‐free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY‐ P72378 , Med Chem Express), DHT + IGF1 (50 ng/mL, HY‐P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP‐AEW541 (10 μM, HY‐50866, Med Chem Express) to eliminate interference from serum‐derived factors.

    Immunohistochemistry:

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome.
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co-cultured with JAr spheroids, Ishikawa cells were primed under serum-free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY-P72378, Med Chem Express), DHT + IGF1 (50 ng/mL, HY-P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP-AEW541 (10 μM, HY-50866, Med Chem Express) to eliminate interference from serum-derived factors.

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co‐cultured with JAr spheroids, Ishikawa cells were primed under serum‐free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY‐ P72378 , Med Chem Express), DHT + IGF1 (50 ng/mL, HY‐P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP‐AEW541 (10 μM, HY‐50866, Med Chem Express) to eliminate interference from serum‐derived factors.

    Staining:

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome.
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co-cultured with JAr spheroids, Ishikawa cells were primed under serum-free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY-P72378, Med Chem Express), DHT + IGF1 (50 ng/mL, HY-P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP-AEW541 (10 μM, HY-50866, Med Chem Express) to eliminate interference from serum-derived factors.

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co‐cultured with JAr spheroids, Ishikawa cells were primed under serum‐free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY‐ P72378 , Med Chem Express), DHT + IGF1 (50 ng/mL, HY‐P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP‐AEW541 (10 μM, HY‐50866, Med Chem Express) to eliminate interference from serum‐derived factors.

    Two Tailed Test:

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome.
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co-cultured with JAr spheroids, Ishikawa cells were primed under serum-free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY-P72378, Med Chem Express), DHT + IGF1 (50 ng/mL, HY-P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP-AEW541 (10 μM, HY-50866, Med Chem Express) to eliminate interference from serum-derived factors.

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co‐cultured with JAr spheroids, Ishikawa cells were primed under serum‐free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY‐ P72378 , Med Chem Express), DHT + IGF1 (50 ng/mL, HY‐P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP‐AEW541 (10 μM, HY‐50866, Med Chem Express) to eliminate interference from serum‐derived factors.

    Comparison:

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome.
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co-cultured with JAr spheroids, Ishikawa cells were primed under serum-free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY-P72378, Med Chem Express), DHT + IGF1 (50 ng/mL, HY-P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP-AEW541 (10 μM, HY-50866, Med Chem Express) to eliminate interference from serum-derived factors.

    Article Title: IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome
    Article Snippet: After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.After treatment with DHT (GlpBio, USA) for 48 h, Ishikawa cells were collected for RNA extraction.. Before co‐cultured with JAr spheroids, Ishikawa cells were primed under serum‐free conditions for 24 h with DHT (0.5 μM), DHT + IGFBP5 (100 ng/mL, HY‐ P72378 , Med Chem Express), DHT + IGF1 (50 ng/mL, HY‐P7018, Med Chem Express), DHT + IGFBP5 + IGF1, or DHT + IGFBP5 + NVP‐AEW541 (10 μM, HY‐50866, Med Chem Express) to eliminate interference from serum‐derived factors.



    Similar Products

    95
    MedChemExpress dht igf1
    Dht Igf1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dht+igf1/IGF-I%2FIGF-1%2C+Human/pm41816941-197-28-34
    Average 95 stars, based on 1 article reviews
    dht igf1 - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results